Duration of Therapy | Outcome | LAP (n = 43) | LAE (n = 95) | LMP (n = 2) | LME (n = 5) | CAP (n = 45) | CAE (n = 52) | CME (n = 3) |
---|
10 days | Success | 18 (78.3) | 14 (50) | NA | NA | 2 (22.2) | 5 (62.5) | NA |
Failure | 5 (21.7) | 14 (50) | NA | NA | 7 (77.8) | 3 (37.5) | NA |
14 days | Success | 14 (70) | 58 (86.6) | 1 (50) | 3 (60) | 23 (63.9) | 32 (72.7) | 0 (0) |
Failure | 6 (30) | 9 (13.4) | 1 (50) | 2 (40) | 13 (36.1) | 12 (27.3) | 3 (100) |
- LAP levofloxacin, amoxicillin, and pantoprazole; LAE levofloxacin, amoxicillin, and esomeprazole, LMP levofloxacin, metronidazole, and pantoprazole, LME levofloxacin, metronidazole, and esomeprazole, CAP clarithro,mycin, amoxicillin, and pantoprazole, CAE clarithromycin, amoxicillin, and esomeprazole, CME clarithromycin, metronidazole, and esomeprazole
- Data are presented as n (%)
- Overall difference between all regimens was significant (P = 0.03)
- None of the included patients received clarithromycin, metronidazole, and pantoprazole